Generali Investments, Management »

Neurocrine Biosciences shares owned by Generali Investments, Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Generali Investments, Management from 13F filings

Historical chart of Generali Investments, Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Generali Investments, Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Generali Investments, Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $696k 5.0k 140.38
2025-06-30 $319k 2.5k 125.52

More positions owned by Generali Investments, Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Netflix (NFLX)
Broadcom (AVGO)
Palo Alto Networks (PANW)
Palantir Technologies Cl A (PLTR)
Eli Lilly & Co. (LLY)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)

View all positions for Generali Investments, Management

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
Jpmorgan Chase & Co
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Morgan Stanley
Wellington Management Company
Bellevue Group
Thomas Stevens, CFA"
Deerfield Management Company
Rtw Investments
Millennium Management

View all funds holding Neurocrine Biosciences